Stephenson, MD, FACS, shares insights on evolving LAL technology and best practices for managing the ocular surface before ...

Aaron Y. Lee, MD, MSCI, explains how temporal optical coherence tomography modeling may improve longitudinal disease tracking and clinical decision-making.

In July 2025, 3 4DMT announced its intent to accelerate its 4D-150 4FRONT phase 3 program in wet AMD and lay off approximately 25% of staff. 4DMT noted that this transition supported the company’s ...

“In GA, light is not transduced into electrical signals because of a loss of photoreceptors, which leads to an absolute scotoma (blind spot). 2,3 The PRIMA neurostimulation system replaces the lost ...

Andrew G. Lee, MD, and Drew Carey, MD, discuss how optic disc cupping after optic neuritis reflects nerve and ganglion cell ...

The 2025 program built on its evolving reputation as a multispecialty educational forum that successfully integrates ophthalmology and optometry, premium CME content, and a family-friendly format to ...

China’s National Medical Products Administration (NMPA) has granted regulatory approval for 2 next-generation ophthalmic ...

Edinburgh Biosciences has reported encouraging early outcomes from a structured long-term safety and performance follow-up ...

The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive ...

This finding was based on the results of a study published in BMJ Open Ophthalmology1 that patients with diabetes who were ...

Discussions from the EnVision Summit 2025 highlighted several clinical and surgical challenges that are expected to shape ...

Early safety and visual performance signals were reported at 3 months from a first-in-human (FIH) clinical study evaluating ...